Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Enter your email address below and subscribe to our newsletter

Notal Vision announced that the FDA has granted De Novo authorization for its patient self-operated Scanly Home OCT device. Designated by the FDA as a breakthrough device for patients suffering from wet age-related macular degeneration (AMD), Scanly Home OCT aims…

The University of Missouri School of Medicine has revealed that the virus responsible for COVID-19 can penetrate the blood-retinal barrier, potentially causing long-term eye complications. The blood-retinal barrier is a crucial defense mechanism, protecting our vision from infections by preventing…

ArcScan, a global medical technology company dedicated to revolutionizing ophthalmic care, marked a significant milestone with the announcement of the National Medical Products Administration (NMPA) approval of its flagship product, the ArcScan Insight® 100, for use in China. Addressing the…

Topcon Healthcare announced a partnership with Microsoft Corporation to deliver AI-powered ‘Healthcare from the Eye’ solutions to improve healthcare access, cost, and quality. A cloud-based connected network of healthcare providers using the ‘Nuance Precision Imaging Network’ and the THI Harmony…

Researchers have unveiled promising findings at the Pediatric Academic Societies (PAS) 2024 Meeting in Toronto, indicating that an eye ultrasound could swiftly and safely diagnose brain drainage tube failures in children at emergency departments. This innovative approach primarily targets children…

Lumibird Medical has unveiled its latest innovation, the C.DIAG, marking a significant advancement in dry eye diagnostic technology. Integrated with AI algorithms, this new component of the C.SUITE is designed to enable the diagnosis, treatment, and education of dry eye…

Topcon Healthcare has announced an investment in RetiSpec, marking the beginning of a collaboration aimed at commercializing RetiSpec’s innovative technology. This partnership intends to bridge the gap between neurology and eye care, potentially transforming how Alzheimer’s disease is detected and…

AEYE Health has received FDA clearance for its fully autonomous AI, making it the first to diagnose referable diabetic retinopathy using a handheld camera. The technology, known as AEYE Diagnostic Screening (AEYE-DS), was previously approved for use with a tabletop…

Inflammasome Therapeutics has officially dosed the first patient in a pioneering clinical trial aimed at treating geographic atrophy (GA) resulting from age-related macular degeneration (AMD). This trial, a first-in-class study for a sustained release implant, is sponsored by the University…

TED is an autoimmune disease in which the eye muscles and fatty tissue behind the eye become inflamed. This inflammation can push the eyes forward (“staring” or “bulging”) or cause the eyes and eyelids to become red and swollen. In…